FDA Submits Collection of Information for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, focusing on testing human blood donors for evidence of infection due to communicable disease agents and donor notification requirements.